Amorolist Cream
Amorolist Cream is a topical antifungal formulation containing Amorolfine (0.25% w/w), designed to treat a range of superficial fungal infections, including dermatophytosis, candidiasis, and onychomycosis (nail fungus). It acts by disrupting the fungal cell membrane synthesis, ultimately weakening and killing the fungus. The cream spreads easily and is suitable for daily application, helping reduce itching, redness, and scaling. Clinically recommended for its broad-spectrum action, Amorolist Cream is a safe and effective solution for managing persistent fungal skin infections under medical supervision.
Product Information
Product Information
Shipping & Returns
Shipping & Returns




Amorolist Cream
Amorolist Cream
Amorolist Cream is a topical antifungal formulation containing Amorolfine (0.25% w/w), designed to treat a range of superficial fungal infections, including dermatophytosis, candidiasis, and onychomycosis (nail fungus). It acts by disrupting the fungal cell membrane synthesis, ultimately weakening and killing the fungus. The cream spreads easily and is suitable for daily application, helping reduce itching, redness, and scaling. Clinically recommended for its broad-spectrum action, Amorolist Cream is a safe and effective solution for managing persistent fungal skin infections under medical supervision.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Amorolist Cream is a topical antifungal formulation containing Amorolfine (0.25% w/w), designed to treat a range of superficial fungal infections, including dermatophytosis, candidiasis, and onychomycosis (nail fungus). It acts by disrupting the fungal cell membrane synthesis, ultimately weakening and killing the fungus. The cream spreads easily and is suitable for daily application, helping reduce itching, redness, and scaling. Clinically recommended for its broad-spectrum action, Amorolist Cream is a safe and effective solution for managing persistent fungal skin infections under medical supervision.























